Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Invivyd To Contact Him Directly To Discuss

NEW YORK, Feb. 11, 2023 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (“Invivyd” or the “Company”) (NASDAQ: IVVD) and reminds investors of the April 3, 2023 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi Logo (PRNewsfoto/Faruqi & Faruqi, LLP)

If you have suffered losses exceeding $100,000 invest in Invivid stock or options between November 29, 2021 and December 14, 2021 and would like to discuss your legal rights, call Faruqi & Faruqi partners Josh Wilson

FTC Announces Public Forum on Proposed Noncompete Ban

The Federal Trade Commission (FTC) has announced that it will be hosting a public forum on February 16, 2022, from 12:00-3:00 pm ET, to discuss its proposed nationwide non-compete ban. The forum is intended to supplement the FTC’s request for written comments, which as of today have exceeded 10,000. According to the FTC, “[t]the commission will hear from a series of speakers who have been subject to non-compete restrictions, as well as business owners who have experience with non-competes.” It is unclear whether any of the “business owners who have experience with non-competitors” support their use, or if the …

The Klein Law Firm Announces a Lead Plaintiff Deadline of April 3, 2023 in the Class Action Filed on Behalf of Invivyd, Inc. f/k/a Adagio Therapeutics, Inc.

NEW YORK, Feb. 7, 2023 /PRNewswire/ — The Klein Law Firm announced that a class action complaint has been filed on behalf of shareholders of Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (NASDAQ: IVVD) alleging that the Company violated federal securities laws.

This lawsuit is on behalf of all purchasers of Adagio common stock between November 29, 2021 and December 14, 2021both dates inclusive.
Lead Plaintiff Deadline: April 3, 2023
No obligation or cost to you.

Learn more about your recoverable losses in IVVD:
https://www.kleinstocklaw.com/pslra-1/invivyd-class-action-submission-form?id=36279&from=4

Invivid, Inc. f/k/a Adagio Therapeutics, Inc. NEWS – IVVD NEWS

CLASS ACTION CASE DETAILS:

ROSEN, A TOP RANKED LAW FIRM, Encourages ESS Tech Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm

Published: Feb. 4, 2023 at 11:45 AM EST|Updated: 21 hours ago

NEW YORK, Feb. 4, 2023 /PRNewswire/ —

Rosen Law Firm, PA Logo
Rosen Law Firm, PA Logo(PRNewswire)

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of ESS Tech Inc. (NYSE:GWH) between August 11, 2022 and December 7, 2022both dates inclusive (the “Class Period”), of the important March 13, 2023 lead plaintiff deadline.

SO WHAT: If you purchased ESS Tech securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or

Legislation Reintroduced in Congress to Ban Non-Compete Agreements and Seeking to Go Even Further than the FTC’s Proposed Ban | Seyfarth Shaw

US Senator Chris Murphy (D-Conn.) and US Senator Todd Young (R-Ind.) on February 1st reintroduced the Workforce Mobility Act. The legislation would ban the use of non-compete agreements with some limited exceptions. US Representative Scott Peters (D-Calif.-52) and US Representative Mike Gallagher (R-Wis.-08) introduced the legislation in the US House of Representatives. US Senator Tim Kaine (D-Va.) and US Senator Kevin Cramer (RN.D.) co-sponsored the legislation. The bill was previously introduced in the House of Representatives in 2021.

“Across industries and income brackets, non-competitives are terrible for workers and a major drag on economic growth. It’s ridiculous we

Webinar Recap! 2022 Trade Secrets & Non-Competes Year in Review | Seyfarth Shaw

In the second installment of the 2023 Trade Secrets Webinar Series, Seyfarth attorneys reviewed noteworthy legislation, cases, and legal developments from across the nation over the last year in the areas of trade secrets and data theft, non-competes and other restrictive covenants, and computer fraud. Plus, they provided predictions for what to expect in 2023.

As a conclusion to this webinar, we compiled a summary of takeaways:

  • The FTC’s attempted regulation of employment non-competes as part of its rulemaking powers is unprecedented in the 109 years since its creation in 1914. The FTC bases its rulemaking authority on Section 5

Kessler Topaz Meltzer & Check, LLP Reminds Investors of February 10, 2023 Deadline in Securities Fraud Class Action Lawsuit against Twist Bioscience Corporation

RADNOR, Pa., Jan. 21, 2023 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities class action lawsuit against Twist Bioscience Corporation (“Twist”) (NASDAQ: TWST) on behalf of investors who purchased or acquired Twist common stock between December 13, 2019 and November 14, 2022, inclusive (the “Class Period”). This action, captioned Peters v. Twist Bioscience Corporation, et al., Case No. 3:22-cv-08168, was filed in the United States District Court for the Northern District of Californian and is assigned to the Honorable Edward J. Davila.

KTMC (PRNewsPhoto/Kessler Topaz Meltzer & Check)

CLICK HERE

Ransomware Attacks: Harmless Annoyances or Catastrophic Events? | Seyfarth Shaw

This post was originally published on Seyfarth’s Gadgets, Gigabytes & Goodwill blog.

Ransomware attacks have become one of the most common and pervasive cybercrimes perpetrated against US companies. A bad actor, often from overseas, will gain access to upload malware onto a company’s network storage or application platforms that encrypt all files it can access. A message or text file is usually left with instructions on how to contact the attacker to pay a ransom for the decryption key. In the worst case, a ransomware attack can freeze the business operations by effectively removing access to the company’s critical systems